Bicara Sets a Multi-Role Leadership Succession

Company: Bicara Therapeutics · Event Type: Leadership Change · Product/Asset: Ryan Cohlhepp · Subject: Leadership · Event Date: August 11, 2026 Summary Bicara Therapeutics announced a planned CEO succession and four additional senior-role changes around the pivotal development of ficerafusp alfa. President and COO Ryan…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Astellas / AviadoBio – Gene Therapy Program Sustained via Nonprofit Funding
Samsung Biologics Moves Into Peptide Manufacturing
Boulevard Bio Launches with $65 Million
GSK – $1B SiranBio Oligo Deal